Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W

Key Points

• Omada Health (NASDAQ:OMDA) has been upgraded to a "hold" rating by Baird R W, reflecting a growing consensus among analysts about the stock's performance.
• The company recently reported earnings that missed estimates, posting a loss of ($0.22) per share against analysts' expectations of ($0.15) but exceeded revenue estimates with $61.37 million.
• Despite the earnings miss, seven analysts rate the stock as a buy, while two have given it a hold rating, suggesting a strong interest from institutional investors.

Omada Health (NASDAQ:OMDA - Get Free Report) was upgraded by research analysts at Baird R W to a "hold" rating in a research note issued on Friday,Zacks.com reports.

OMDA has been the topic of several other reports. Wall Street Zen raised Omada Health to a "hold" rating in a research report on Monday, June 16th. Canaccord Genuity Group upped their price target on Omada Health from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Friday, August 8th. JPMorgan Chase & Co. assumed coverage on Omada Health in a research report on Tuesday, July 1st. They set an "overweight" rating and a $19.00 price target on the stock. The Goldman Sachs Group assumed coverage on Omada Health in a research report on Tuesday, July 1st. They set a "buy" rating and a $29.00 price target on the stock. Finally, Evercore ISI upped their price target on Omada Health from $21.00 to $23.00 and gave the company an "outperform" rating in a research report on Wednesday, July 9th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $24.50.

Omada Health Stock Up 2.1%

OMDA stock traded up $0.46 during midday trading on Friday, hitting $22.04. 266,542 shares of the company's stock were exchanged, compared to its average volume of 625,243. Omada Health has a 12-month low of $14.14 and a 12-month high of $28.40. The business has a 50 day moving average of $19.97.

Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The business had revenue of $61.37 million during the quarter, compared to the consensus estimate of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OMDA. Perceptive Advisors LLC acquired a new position in Omada Health during the 2nd quarter valued at approximately $44,402,000. Loomis Sayles & Co. L P acquired a new position in Omada Health during the 2nd quarter valued at approximately $19,948,000. Sanofi bought a new position in shares of Omada Health in the second quarter worth $9,606,000. Federated Hermes Inc. bought a new position in shares of Omada Health in the second quarter worth $9,150,000. Finally, Norges Bank bought a new position in shares of Omada Health in the second quarter worth $5,490,000.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.